Israel Englander’s Integra LifeSciences IART Stock Holding History

Israel Englander’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,000	Closed	-$291K	–	6253
2024 Q2	$291K	Buy	+10,000	New	+$297K	﹤0.01%	4931
2023 Q3	–	Sell	-10,000	Closed	-$411K	–	6309
2023 Q2	$411K	Buy	+10,000	New	+$481K	﹤0.01%	4670
2023 Q1	–	Sell	-15,000	Closed	-$841K	–	6577
2022 Q4	$841K	Buy	+15,000	New	+$763K	﹤0.01%	4333
2022 Q1	–	Sell	-10,000	Closed	-$670K	–	7143
2021 Q4	$670K	Buy	+10,000	New	+$677K	﹤0.01%	4780
2021 Q3	–	Sell	-20,000	Closed	-$1.36M	–	6987
2021 Q2	$1.36M	Buy	+20,000	New	+$1.41M	﹤0.01%	4367
2021 Q1	–	Sell	-20,000	Closed	-$1.3M	–	6185
2020 Q4	$1.3M	Buy	+20,000	New	+$1.08M	﹤0.01%	3560
2020 Q1	–	Sell	-70,000	Closed	-$4.08M	–	4139
2019 Q4	$4.08M	Buy	70,000 +40,000	+133%	+$2.38M	0.01%	2094
2019 Q3	$1.8M	Buy	30,000 +15,000	+100%	+$894K	﹤0.01%	2507
2019 Q2	$838K	Sell	15,000 -35,000	-70%	-$1.8M	﹤0.01%	2908
2019 Q1	$2.79M	Buy	+50,000	New	+$2.55M	﹤0.01%	2186
2018 Q4	–	Sell	-10,000	Closed	-$659K	–	3928
2018 Q3	$659K	Buy	+10,000	New	+$621K	﹤0.01%	3094
2017 Q4	–	Sell	-20,000	Closed	-$1.01M	–	3915
2017 Q3	$1.01M	Buy	+20,000	New	+$1.03M	﹤0.01%	2506

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Israel Englander's IART Position: Q2 2026 in Review

Israel Englander increased its Integra LifeSciences (IART) stake by 131% in Q2 2026, buying an estimated $11.4M and bringing the position to 1,439,747 shares worth $25.9M. The position accounts for 0.01% of the portfolio, ranked #1395.

Israel Englander first reported a position in IART in Q3 2013 and has held it in 40 quarters since. The position peaked at $59.3M in Q1 2017. 211 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Israel Englander held 1,439,747 shares of Integra LifeSciences worth $25.9M as of Q2 2026.
Israel Englander bought 816,894 Integra LifeSciences shares in Q2 2026, an estimated $11.4M.
Integra LifeSciences made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1395 holding.
Israel Englander first reported a position in Integra LifeSciences in Q3 2013 and has held it in 40 quarters since.
Israel Englander's Integra LifeSciences position peaked at $59.3M in Q1 2017.
211 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.